Adrenal Bone Cardiovascular Diabetes Endocrine-Disrupting Chemicals Endocrine-Related Cancer Metabolism Neuroendocrinology Obesity Reproduction Steroid and Steroidogenesis Thyroid

Bone

| Recent articles | share

Polyendocrine Metabolic Ovarian Syndrome (PMOS) is the new name for PCOS

Polyendocrine Metabolic Ovarian Syndrome: New name to improve diagnosis and care of condition affecting 170 million women worldwide. A global effort through the International PCOS Network has changed the name of a significant women’s health condition that was misunderstood to be ‘all about ovarian cysts’.

New online medicine support service launched by the Royal Osteoporosis Society (ROS)

The Royal Osteoporosis Society (ROS) has recently launched a new medicine support service called BoneMed Online for people with osteoporosis who have been prescribed a bone-strengthening medicine to reduce the risk of fractures.

Have your say in the State of Endocrinology 2025 Survey

Calling all clinicians, clinician-scientists and biomedical researchers to complete the 'State of Endocrinology 2025 Survey' - this is your chance to raise your voice!

ISE selects Bioscientifica as its association management provider

Bioscientifica is delighted to announce that it has been selected as the new association management provider for the International Society of Endocrinology (ISE), effective January 2025. This appointment follows a competitive selection process led by the ISE Board.

Clarivate announces 2023 Journal Impact Factors

Clarivate, owner of Web of Science, the citation index of scientific and scholarly publishing, has published its 2023 Journal Impact Factors as part of its 2024 Journal Citation Reports. We are delighted to announce significant increases in Journal Impact Factors for Reproduction and Fertility and EFORT Open Reviews. Reproduction and Fertility, an official journal of the Society for Reproduction and Fertility (SRF) has achieved a 2023 figure of 2.8.